Why the study?
LAAC with the Watchman device prevents thromboembolism in AF patients, but thrombus may develop on the atrial surface of the device.
What are the incidence and predictors of device-related thrombus in patients with atrial fibrillation treated with left atrial appendage closure?
What are the incidence and predictors of device-related thrombus in patients with atrial fibrillation treated with left atrial appendage closure?
Answers are grounded in this paper and cite their sources.
Device-related thrombus is a rare complication after Watchman implantation that is associated with specific patient and procedural characteristics.
Introduction: Left atrial appendage closure (LAAC) with Watchman device prevents thromboembolism in patients with atrial fibrillation (AF). However, thrombus may develop on the atrial surface of the device. Aim: To investigate the incidence and predictors of device-related thrombus (DRT) in patients with AF who were treated with LAAC. Material and methods: = 78) who had clinical follow-up visits with transesophageal echocardiography (TEE) after the procedure. Conclusions: The DRT after Watchman device implantation remains a rare complication. Its formation was related to several patient and procedural characteristics, which need to be confirmed in larger studies.
No takes yet. Share an insight, caveat, or question.
Maksym et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: